Clinical Trials
14 trialsNCT05119335 2025-11-12
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
NiKang Therapeutics, Inc.
Phase 1/2 Terminated
NCT02706197 2023-09-21
Oxygen Measurements in Subcutaneous Tumors by EPR Oximetry Using OxyChip
Dartmouth-Hitchcock Medical Center
Phase NA Terminated
NCT01827709 2023-04-03
Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma
Universitaire Ziekenhuizen KU Leuven
Phase NA Terminated
NCT02449681 2023-01-12
Study for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin
Rain Oncology Inc
Phase 2 Terminated
NCT02454842 2023-01-12
TH-4000
Rain Oncology Inc
Phase 2 Terminated
NCT03365076 2023-01-09
EXIPOX
University Hospital of North Norway
Phase NA Terminated
NCT03513042 2022-12-06
ERM-PT-HNSCC
Leiden University Medical Center
Terminated
NCT03466034 2020-01-29
The Role of Hypoxia as a Selective Pressure for TP53 Mutations
Institute of Cancer Research, United Kingdom
Terminated
NCT02233387 2019-03-08
HX4-cervix
Maastricht Radiation Oncology
Phase 2 Terminated
NCT02584400 2019-03-08
HX4 SD
Maastricht Radiation Oncology
Phase 2 Terminated
NCT01210378 2019-02-15
Nitroglycerin
Maastricht Radiation Oncology
Phase 2 Terminated
NCT00358397 2016-10-14
One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Terminated
NCT01118819 2016-01-20
Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
BioMed Valley Discoveries, Inc
Phase 1 Terminated
NCT00159978 2015-05-07
Validation of 18F-MISO-PET and 18F-FLT-PET
Radboud University Medical Center
Terminated